FLYE vs REGN · rev $25.4M vs P/E 14, rev $14.34B
Fly-E Group, Inc. Common Stock (FLYE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Fly-E Group, Inc. Common Stock (FLYE) is a auto manufacturers company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FLYE revenue for 2025-03-31 was $25.4M. Net income was -$5.3M. Revenue was down 21.0% from 2024-03-31 to 2025-03-31. FLYE currently screens at market cap $3.8M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FLYE currently screens at market cap $3.8M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FLYE and REGN stock pages for the full models.
Not investment advice.